The distribution of costs of care in mechanically ventilated patients with chronic obstructive pulmonary disease

Abstract

Costs of ICU and non-ICU respiratory care for patients with COPD are higher than costs of care for other mechanically ventilated patients. Although the increased cost of bronchodilators and oximetry in these patients may serve as target areas for reductions in respiratory care costs, it may also be true that these modalities of therapy and management are necessary and need to be used with even greater intensity to achieve better outcomes. The predominant contributions of bed and pharmacy costs in all of our patients with respiratory failure support research efforts addressing these aspects of care.

Intensive Care Cost Analysis Of Patients With Acute Exacerbations Of Chronic Obstructive Pulmonary Diseases From Two University Hospitals

“…There was statistically significant difference (p<0.05). We found that the mortality rate was 42.9%, this result was higher than previous studies, [8,9,11,12,14,15] but in our study all of the patients had respiratory failure and had mechanical ventilation.…”

“…[8][9][10][11][12][13][14][15] Añón et al [8] analysed the prognosis and costs of mechanical ventilation in patients with exacerbations of COPD in an university hospital ICU. They found that the mean age was 64 years (44-77).…”

“…The mean length of stay in the ICU was 41 days and mortality rate was 35% in the ICU, like this study. Ely et al [9] made a study to delineate the costs of care of patients with COPD and found that the mean age was 65 years. The mean length of stay in the ICU was 9 days and mortality rate was 38.6%.…”

“…[8][9][10][13][14][15] Añón et al [8] evaluated 206 admissions due to COPD, 20 patients met the inclusion criteria of their study and demonstrated that the total cost in the ICU was U.S. $1359061, with a mean cost per patient of U.S. $67953. They did not demonstrate the composition of intensive care costs.…”

“…[6,7] Even though cost studies have been conducted in some countries, [8][9][10][11][12][13][14][15] the detailed cost of acute exacerbations of COPD in ICU in Turkey has not been studied.…”